Literature DB >> 17023298

Treatment of pulmonary arterial hypertension with sildenafil: from pathophysiology to clinical evidence.

Shahzad G Raja1, Mark D Danton, Kenneth J MacArthur, James C Pollock.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17023298     DOI： 10.1053/j.jvca.2005.12.011

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN： 1053-0770            Impact factor:   2.628


× No keyword cloud information.
  10 in total

1.  Should we administer sildenafil to patients with acute respiratory distress syndrome? No.

Authors:  Silvio A Namendys-Silva; Marisol Hernández-Garay; Eduardo Rivero-Sigarroa
Journal:  Intensive Care Med       Date:  2010-03-24       Impact factor: 17.440

2.  Sodium tanshinone IIA sulfonate for pulmonary arterial hypertension: emerging therapeutic option.

Authors:  Shahzad G Raja
Journal:  J Thorac Dis       Date:  2013-04       Impact factor: 2.895

3.  Response to a single dose of sildenafil in single-ventricle patients: an echocardiographic evaluation.

Authors:  Kimberly W Jackson; Ryan J Butts; Amy J Svenson; Tim C McQuinn; Andrew M Atz
Journal:  Pediatr Cardiol       Date:  2012-07-18       Impact factor: 1.655

4.  Nitric oxide and pulmonary hypertension.

Authors:  Ji-Yeon Sim
Journal:  Korean J Anesthesiol       Date:  2010-01-31

5.  Tadalafil: the evidence for its clinical potential in the treatment of pulmonary arterial hypertension.

Authors:  Stuart D Katz
Journal:  Core Evid       Date:  2008-07-31

6.  Effect of phospodiesterase 5 inhibitors on apoptosis and nitric oxide synthases in testis torsion: an experimental study.

Authors:  Hüseyin Ustün; K Turgay Akgül; Ali Ayyildiz; Hatice Yağmurdur; Bariş Nuhoğlu; Ersagun Karagüzel; Elmas Oğüş; Cankon Germiyanoğlu
Journal:  Pediatr Surg Int       Date:  2007-11-06       Impact factor: 1.827

7.  Treating pulmonary arterial hypertension: current treatments and future prospects.

Authors:  Shahzad G Raja; Shahbaz M Raja
Journal:  Ther Adv Chronic Dis       Date:  2011-11       Impact factor: 5.091

Review 8.  Sildenafil: a review of its use in pulmonary arterial hypertension.

Authors:  Katherine F Croom; Monique P Curran
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 9.  Sildenafil 4.0-Integrated Synthetic Chemistry, Formulation and Analytical Strategies Effecting Immense Therapeutic and Societal Impact in the Fourth Industrial Era.

Authors:  Andreas Ouranidis; Anastasia Tsiaxerli; Elisavet Vardaka; Catherine K Markopoulou; Constantinos K Zacharis; Ioannis Nicolaou; Dimitris Hatzichristou; Anna-Bettina Haidich; Nikolaos Kostomitsopoulos; Kyriakos Kachrimanis
Journal:  Pharmaceuticals (Basel)       Date:  2021-04-15

10.  Why sildenafil and sildenafil citrate monohydrate crystals are not stable?

Authors:  Somchai Sawatdee; Chaveng Pakawatchai; Kwanjai Nitichai; Teerapol Srichana; Hirihattaya Phetmung
Journal:  Saudi Pharm J       Date:  2015-01-24       Impact factor: 4.330
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.